Xponance Inc. Raises Stake in Crocs, Inc. (NASDAQ:CROX)

Xponance Inc. raised its stake in shares of Crocs, Inc. (NASDAQ:CROX) by 1.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 14,052 shares of the textile maker’s stock after buying an additional 177 shares during the quarter. Xponance Inc.’s holdings in Crocs were worth $1,313,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Assenagon Asset Management S.A. grew its stake in Crocs by 60.1% during the third quarter. Assenagon Asset Management S.A. now owns 1,024,452 shares of the textile maker’s stock valued at $90,387,000 after acquiring an additional 384,390 shares in the last quarter. Pacer Advisors Inc. grew its position in shares of Crocs by 13.4% during the 4th quarter. Pacer Advisors Inc. now owns 771,305 shares of the textile maker’s stock valued at $72,048,000 after purchasing an additional 91,318 shares in the last quarter. AQR Capital Management LLC increased its holdings in shares of Crocs by 141.1% in the third quarter. AQR Capital Management LLC now owns 720,554 shares of the textile maker’s stock worth $63,574,000 after purchasing an additional 421,712 shares during the period. Voss Capital LLC raised its position in shares of Crocs by 610.0% in the third quarter. Voss Capital LLC now owns 710,000 shares of the textile maker’s stock worth $62,643,000 after buying an additional 610,000 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Crocs by 4.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 672,330 shares of the textile maker’s stock valued at $59,320,000 after buying an additional 30,761 shares during the period. 93.44% of the stock is currently owned by institutional investors.

Crocs Trading Down 0.5 %

NASDAQ CROX opened at $125.77 on Thursday. The company has a current ratio of 1.30, a quick ratio of 0.75 and a debt-to-equity ratio of 1.13. Crocs, Inc. has a 1-year low of $74.00 and a 1-year high of $150.56. The stock has a 50-day moving average of $128.14 and a 200-day moving average of $107.07. The firm has a market cap of $7.61 billion, a PE ratio of 9.82, a price-to-earnings-growth ratio of 1.58 and a beta of 2.01.

Crocs (NASDAQ:CROX) last announced its quarterly earnings results on Thursday, February 15th. The textile maker reported $2.58 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.20. The business had revenue of $960.10 million during the quarter, compared to analysts’ expectations of $958.39 million. Crocs had a net margin of 20.00% and a return on equity of 61.97%. The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.65 EPS. As a group, sell-side analysts forecast that Crocs, Inc. will post 12.46 EPS for the current year.

Insider Buying and Selling at Crocs

In other Crocs news, Director John B. Replogle bought 1,972 shares of Crocs stock in a transaction dated Thursday, March 14th. The shares were purchased at an average cost of $126.75 per share, with a total value of $249,951.00. Following the completion of the purchase, the director now owns 3,153 shares of the company’s stock, valued at $399,642.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, President Michelle Poole sold 5,074 shares of the business’s stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $124.98, for a total transaction of $634,148.52. Following the transaction, the president now owns 52,966 shares in the company, valued at $6,619,690.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director John B. Replogle acquired 1,972 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were purchased at an average cost of $126.75 per share, for a total transaction of $249,951.00. Following the completion of the transaction, the director now owns 3,153 shares in the company, valued at approximately $399,642.75. The disclosure for this purchase can be found here. Insiders sold 39,867 shares of company stock valued at $4,786,276 in the last 90 days. Insiders own 2.69% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on CROX. Stifel Nicolaus upped their target price on Crocs from $132.00 to $140.00 and gave the stock a “buy” rating in a research note on Friday, February 16th. KeyCorp raised their target price on shares of Crocs from $130.00 to $149.00 and gave the company an “overweight” rating in a research note on Thursday, March 21st. B. Riley boosted their price target on shares of Crocs from $95.00 to $122.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 10th. Piper Sandler raised their price objective on shares of Crocs from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Friday, February 16th. Finally, Williams Trading reiterated a “hold” rating and issued a $125.00 target price (down from $135.00) on shares of Crocs in a research report on Tuesday, April 16th. Four equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $145.17.

Crocs Profile

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.